©2020 AEA3 WEB
Image default
News

Rishi Sunak refuses to say if he will profit from Moderna Covid vaccine

Chancellor’s former hedge fund invested heavily in Moderna, which had 94.5% trial success

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The chancellor, Rishi Sunak, has refused to disclose whether he will profit from a surge in the share price of the Covid-19 vaccine manufacturer Moderna, one of the biggest investments held by the hedge fund he co-founded before entering parliament.

Moderna has become the latest biotech firm to announce successful trials of its vaccine, declaring on Monday that it was 94.5% effective in trials.

Continue reading…

Related posts

Police investigate I’m a Celebrity over fears non-native bugs may be escaping

AEA3

Seventy-two people arrested after boat intercepted off East Anglia

AEA3

Twitter softens policy on hacking after row over blocked New York Post story

AEA3

Your ads here. Click here